| Previous close | 68.23 |
| Open | 68.57 |
| Bid | 68.11 x 800 |
| Ask | 70.21 x 3000 |
| Day's range | 68.45 - 69.53 |
| 52-week range | 26.49 - 77.49 |
| Volume | 543,182 |
| Avg. volume | 2,072,390 |
| Market cap | 17.865B |
| Beta (5Y monthly) | 1.40 |
| PE ratio (TTM) | 16.51 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Hologic to Showcase Products Across Breast Cancer Screening, Biopsy, Surgery and Treatment at Virtual RSNA 2020
Hologic to Showcase Products Across Breast Cancer Screening, Biopsy, Surgery and Treatment at Virtual RSNA2020
- Business Wire
Hologic to Webcast Presentation at Upcoming Virtual Investor Conference
Hologic to Webcast Presentation at Upcoming Virtual Investor Conference
- Business Wire
Aptima HIV-1 Quant Dx Assay Receives Additional FDA Approval for Use as an Aid in the Diagnosis of HIV Infection
Aptima® HIV-1 Quant Dx Assay Receives Additional FDA Approval for Use as an Aid in the Diagnosis of HIV Infection
© 2020 Verizon Media. All rights reserved.
